Although the cellular mechanisms have not been fully elucidated, truncating somatic JAK1 mutations in gynecological carcinomas reduced IFNγ-induced MHC class I expression at the tumor cell surface, which could reduce immune recognition and facilitate immune evasion (17). The gene discussed is JAK1; the disease is neoplasm.